Literature DB >> 28225974

Do you know this syndrome? Hand-foot syndrome.

Cintia Santos Braghiroli1, Rodrigo Ieiri1, Juliana Polizel Ocanha1, Rafael Bispo Paschoalini2, Hélio Amante Miot1.   

Abstract

Hand-foot syndrome is a common cutaneous adverse effect associated with certain systemic chemotherapy drugs. It is characterized by erythema, edema, and burning sensation, especially over palmoplantar surfaces. We report the case of an elderly patient undergoing chemotherapy after a breast cancer surgery who developed symptoms two months after the start of the regimen. There are no studies that explore specific therapies. Suggestive therapy include reducing agent dosage, increasing the interval between cycles, or even stopping chemotherapy. Emollients, analgesics, and cold packs are described as effective. After alopecia and mucositis, hand-foot syndrome is the most common adverse dermatologic reaction to chemotherapeutic agents.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28225974      PMCID: PMC5312196          DOI: 10.1590/abd1806-4841.20174602

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


  10 in total

1.  Sunitinib: a cause of bullous palmoplantar erythrodysesthesia, periungual erythema, and mucositis.

Authors:  Pitiporn Suwattee; Steven Chow; Brian C Berg; Erin M Warshaw
Journal:  Arch Dermatol       Date:  2008-01

2.  Efficient prevention strategy against the development of a palmar-plantar erythrodysesthesia during chemotherapy.

Authors:  Juergen Lademann; Anja Martschick; Franziska Kluschke; Heike Richter; Joachim W Fluhr; Alexa Patzelt; Sora Jung; Radoslav Chekerov; Maxim E Darvin; Norbert Haas; Wolfram Sterry; Leonhard Zastrow; Jalid Sehouli
Journal:  Skin Pharmacol Physiol       Date:  2013-08-21       Impact factor: 3.479

3.  Prevention of palmar-plantar erythrodysesthesia with an antiperspirant in breast cancer patients treated with pegylated liposomal doxorubicin (SAKK 92/08).

Authors:  Arnoud J Templeton; Karin Ribi; Christian Surber; Hong Sun; Shu-Fang Hsu Schmitz; Michael Beyeler; Daniel Dietrich; Markus Borner; Annette Winkler; Andreas Müller; Lukas von Rohr; Ralph C Winterhalder; Christoph Rochlitz; Roger von Moos; Khalil Zaman; Beat J K Thürlimann; Thomas Ruhstaller
Journal:  Breast       Date:  2014-03-20       Impact factor: 4.380

4.  [Inflammation of multiple seborrheic keratoses induced by chemotherapy with gemcitabine].

Authors:  Caio Roberto Shwafaty de Siqueira; Hélio Amante Miot
Journal:  An Bras Dermatol       Date:  2009 Jul-Aug       Impact factor: 1.896

Review 5.  Chemotherapy-induced hand-foot syndrome and nail changes: a review of clinical presentation, etiology, pathogenesis, and management.

Authors:  Kristen K Miller; Loren Gorcey; Beth N McLellan
Journal:  J Am Acad Dermatol       Date:  2014-05-01       Impact factor: 11.527

Review 6.  Prophylactic and therapeutic efficacy of pyridoxine supplements in the management of hand-foot syndrome during chemotherapy: a meta-analysis.

Authors:  S J Jo; H Shin; S Jo; O Kwon; S-K Myung
Journal:  Clin Exp Dermatol       Date:  2014-12-31       Impact factor: 3.470

Review 7.  Palmar-plantar erythrodysesthesia (PPE): a literature review with commentary on experience in a cancer centre.

Authors:  Joan D Webster-Gandy; Chris How; Karen Harrold
Journal:  Eur J Oncol Nurs       Date:  2007-03-09       Impact factor: 2.398

8.  Palmar-plantar erythrodysesthesia associated with scrotal and penile involvement with capecitabine.

Authors:  Christy M Sapp; Philip DeSimone
Journal:  Clin Colorectal Cancer       Date:  2007-01       Impact factor: 4.481

Review 9.  Adverse mucocutaneous reactions to chemotherapeutic agents: part I.

Authors:  Jose Antonio Sanches Junior; Hebert Roberto Clivati Brandt; Emanuella Rosyane Duarte Moure; Guilherme Luiz Stelko Pereira; Paulo Ricardo Criado
Journal:  An Bras Dermatol       Date:  2010 Jul-Aug       Impact factor: 1.896

10.  The pathogenetic mechanism of anthracycline-induced palmar-plantar erythrodysesthesia.

Authors:  A Martschick; J Sehouli; Alexa Patzelt; H Richter; U Jacobi; G Oskay-Ozcelik; W Sterry; J Lademann
Journal:  Anticancer Res       Date:  2009-06       Impact factor: 2.480

  10 in total
  1 in total

Review 1.  Loss of Fingerprints as a Side Effect of Capecitabine Therapy: Case Report and Literature Review.

Authors:  Jian Zhao; Xia Zhang; Xiaonan Cui; Di Wang; Bin Zhang; Liying Ban
Journal:  Oncol Res       Date:  2019-09-26       Impact factor: 5.574

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.